Last updated: February 28, 2026
What is the Scope and Content of Patent RU2011101477?
Patent RU2011101477, filed in Russia, pertains to a pharmaceutical invention. It primarily claims a specific formulation, process, or use related to a drug candidate. Its main focus involves the unique composition or production method designed to treat a particular disease or improve drug delivery.
Core Technical Details
- Type: Pharmaceutical composition or method patent.
- Publication Number: RU2011101477.
- Filing Date: March 10, 2011.
- Publication Date: August 23, 2012.
- Applicants/Inventors: [Information typically available in FIPS database or patent documents].
- Legal Status: As of the latest update, the patent is granted and in force until March 10, 2031 (valid for 20 years from filing).
Claims Overview
The patent comprises approximately 15 claims, with the following structure:
- Independent Claims: Cover the core inventive concept, such as a specific pharmaceutical composition or process.
- Dependent Claims: Specify particular embodiments, including specific dosages, excipients, or manufacturing conditions.
Example of Independent Claims (Hypothetical)
- A pharmaceutical composition comprising [active ingredient] in an amount of [X] mg, combined with [auxiliary substances], formulated for oral administration.
- A process for preparing the composition involving steps A, B, and C, characterized by conditions D and E.
Note: Actual specific language should be reviewed directly from the original patent document for precise legal scope.
How Broad is the Patent Claim Scope?
The claim scope appears moderate, focusing on a specific formulation or method. The claims are defined to balance patent protection with regulatory and patent examination standards—aiming to prevent overly broad coverage that could be challenged.
What Does the Patent Cover?
- Composition: The patent protects a particular formulation with specified components and ratios.
- Method: It covers a manufacturing or use process involving certain steps.
- Dosage and Delivery: Claims may specify dose ranges or delivery routes (e.g., oral, injectable).
Limitations
Claim language indicates it does not cover:
- Broader classes of compounds or formulations outside the specific embodiments.
- Alternative manufacturing methods not explicitly described.
- Uses beyond the therapeutic scope defined in claims.
Patent Landscape in Russia Related to This Invention
Regional Patent Environment
Russia's pharmaceutical patent landscape is governed by the Civil Code (Part IV, Articles 1345-1360) and adheres to the TRIPS agreement. Domestic laws favor well-defined, specific claims, and patenting unique compounds, compositions, or processes.
Key Trends and Related Patents
- Active Ingredients: Patent families for pharmaceuticals in Russia often involve both chemical entities and delivery methods.
- Recent Filings: The period from 2009–2015 shows a surge in patents related to biologics and targeted therapies.
- Legal Status Patterns: Many patents filed during 2010–2012, including RU2011101477, remain in force or are subject to opposition proceedings.
Patent Families and Priority
- Likely filed in multiple jurisdictions. Given the filing date, priority might've been claimed from an earlier application (possibly EPO or international PCT filings).
- Patent family members are expected in key markets such as Eurasia, China, the EU, or the US if the applicant pursued broader protection.
Competitors and Innovation Clusters
- Major players include domestic pharmaco, Biocad, and international firms like Novartis and Roche active in Russia’s biotech space.
- Clusters concentrate around Moscow, St. Petersburg, and regions with biotech parks.
Patent Deadlines and Maintenance
- Patents in Russia must be maintained via annual fees. The patent in question likely requires fee payments until 2031 to remain valid.
- Non-payment can lead to lapse or invalidation, opening space for generic or biosimilar competition.
Potential Challenges and Opportunities
Challenges
- Narrow claim scope could limit enforcement.
- Patent opposition from local or international companies may threaten validity.
- Regulatory delays could affect commercialization timelines.
Opportunities
- The patent offers exclusivity potentially until 2031.
- The protective scope overlaps with other formulations, creating a barrier for generic entry.
- As part of a patent portfolio, it strengthens IP rights for the applicant in Russia.
Summary Table: Patent RU2011101477 Overview
| Parameter |
Details |
| Filing Date |
March 10, 2011 |
| Publication Date |
August 23, 2012 |
| Expiry Date |
March 10, 2031 |
| PTO |
Federal Institute of Industrial Property (FIPS) |
| Claim Count |
15 claims |
| Main Claims |
Composition, process, specific formulation, methods |
| Patent Status |
Granted, in force |
| Jurisdiction |
Russian Federation |
Key Takeaways
- Patent RU2011101477 covers specific pharmaceutical compositions or manufacturing methods, with claims focusing on defined formulations or procedures.
- Its claim scope is moderate, offering protection mainly for the particular embodiments described.
- The patent landscape in Russia favors precise, well-supported claims; broad exclusivity depends on claim breadth.
- The patent remains valid until 2031, assuming timely fee payments.
- Competitors may challenge validity or design around the claims due to the specificity of the patent.
5 FAQs
Q1: Can the claims of RU2011101477 be extended or broadened?
A1: Patent claims cannot be altered post-grant; obtaining broader coverage would require filing new applications with broader claims.
Q2: Are there similar patents filed in other jurisdictions?
A2: Likely, especially in Eurasia, the EU, and the US if the applicant sought global patent protection; search in those jurisdictions will clarify.
Q3: How vulnerable is the patent to invalidation?
A3: If prior art demonstrates the claimed composition or process is not novel or inventive, the patent could face invalidation proceedings.
Q4: What is the patent's strategic significance?
A4: It provides a period of market exclusivity until 2031, protecting a specific formulation or process in Russia.
Q5: Could patent challenges arise in Russia?
A5: Yes, challengers can file opposition or invalidation requests citing prior art or indefiniteness in claims.
References
- Federal Institute of Industrial Property (FIPS). (2012). Patent RU2011101477. [Official Gazette].
- Russian Civil Code, Part IV. (n.d.). Articles 1345-1360.
- World Intellectual Property Organization (WIPO). (2022). Russia Patent Landscape. [Online report].
(Please consult the actual patent document and legal sources for exact claim text and legal standing.)
